Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(10%)
Results Posted
125%(5 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_1
4
40%
Ph phase_3
1
10%
Ph phase_4
5
50%

Phase Distribution

4

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(3)
Other(2)

Detailed Status

Completed4
Terminated2
Suspended1
unknown1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (40.0%)
Phase 31 (10.0%)
Phase 45 (50.0%)

Trials by Status

completed440%
suspended110%
unknown110%
withdrawn110%
terminated220%
active_not_recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
active_not_recruitingphase_4

Ketamine + Cognitive Training for Suicidality in the Medical Setting

NCT04578938
withdrawnphase_1

Repeated Neurocognitive Measurements in Depressed Patients

NCT05991232
completedphase_4

IV and Intrathecal Ketamine in Cesarean Section

NCT05679375
completedphase_1

Ketamine + Mindfulness for Depression

NCT05168735
completedphase_1

Repeated Neurocognitive Measurements in Depressed Patients

NCT04916548
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04578938Phase 4

Ketamine + Cognitive Training for Suicidality in the Medical Setting

Active Not Recruiting
NCT05991232Phase 1

Repeated Neurocognitive Measurements in Depressed Patients

Withdrawn
NCT05679375Phase 4

IV and Intrathecal Ketamine in Cesarean Section

Completed
NCT05168735Phase 1

Ketamine + Mindfulness for Depression

Completed
NCT04916548Phase 1

Repeated Neurocognitive Measurements in Depressed Patients

Completed
NCT04154150Phase 4

Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot

Terminated
NCT03237286Phase 1

Intravenous Ketamine Plus Neurocognitive Training for Depression

Completed
NCT03674671Phase 3

Ketamine Versus Electroconvulsive Therapy in Depression

Suspended
NCT03781817Phase 4

Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures

Terminated
NCT03221569Phase 4

Ketamine v. Ketorolac for Management of Generalized Tension Type Headache

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10